Study of the Safety and Tolerability of P 321 Ophthalmic Solution in Subjects With Dry Eye Disease
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Dry Eye Disease
Related studies linked through entity extraction aliases.
The Utility of IVCM to Assess Cellular Response and Efficacy of Long-term Topical Steroid Treatment in Patients With DED
- Status
- COMPLETED
- Phase
- PHASE4
NovaTears® Eye Drops Observational Study
- Status
- COMPLETED
- Phase
- N/A
Ocular Surface Immune Response in Dry Eye Disease
- Status
- COMPLETED
- Phase
- N/A
A Phase IV, Randomized, Parallel Group, Investigator-Masked Evaluation of the Effect of Loteprednol Etabonate Ophthalmic Gel 0.5% on the Initiation of Dry Eye Treatment With Restasis®
- Status
- WITHDRAWN
- Phase
- PHASE4
Dry Eye Disease in the Vitamin D and Omega-3 Trial (VITAL)
- Status
- UNKNOWN
- Phase
- NA
Systane Ultra Versus Maxidex Versus Saline
- Status
- COMPLETED
- Phase
- NA
A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry Eye
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Compare the Safety and Efficacy of A New Eye Drop Formulation With OPTIVE™ in Subjects With Dry Eye Disease
- Status
- COMPLETED
- Phase
- PHASE3
Evaluation of Ocular Comfort With ISTA Tears vs Systane
- Status
- COMPLETED
- Phase
- NA
Safety Study of Lifitegrast to Treat Dry Eye
- Status
- COMPLETED
- Phase
- PHASE3
A Dose-Finding Study Comparing InSite Vision, Inc. 101 to Vehicle and DuraSite Alone for Dry Eye Disease
- Status
- WITHDRAWN
- Phase
- PHASE2
A Study Assessing the Safety and Efficacy of DE-101 Ophthalmic Suspension in Dry Eye Patients
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Efficacy Study of SAR 1118 to Treat Dry Eye Conducted in a Controlled Adverse Environment (CAE) (OPUS-1)
- Status
- COMPLETED
- Phase
- PHASE3
Diurnal Variation in Tear Osmolarity
- Status
- COMPLETED
- Phase
- N/A
Evaluation of Anti-Inflammatory Treatment in Dry Eye Patients
- Status
- COMPLETED
- Phase
- PHASE2
A Four Week Study of Azithromycin Ophthalmic Solution, 1% Versus Placebo in Subjects With Dry Eye Disease
- Status
- COMPLETED
- Phase
- PHASE4
The Effects of Diquafosol Tetrasodium Ophthalmic Solution, 2% in Subjects With Dry Eye Disease (P08637)
- Status
- COMPLETED
- Phase
- PHASE3
Physician's Evaluation of Cyclosporine Ophthalmic Emulsion 0.05%
- Status
- COMPLETED
- Phase
- N/A
Exploratory Study Comparing Signs and Symptoms in Patients With Ocular Hypertension or Glaucoma Using Xalatan R® or Travatan Z®
- Status
- COMPLETED
- Phase
- PHASE4